These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 10792498)

  • 1. Native IgG2a(b) is barely antigenic to major histocompatibility complex class II-restricted T cells owing to inefficient internalization by professional antigen-presenting cells.
    Bartnes K; Hannestad K
    Immunology; 2000 Apr; 99(4):510-22. PubMed ID: 10792498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genes predisposing to autoimmunity augment constitutive major histocompatibility complex class II-associated presentation of the self-antigen IgG2a in vivo.
    Bartnes K; Li X; Iwamoto M; Izui S; Hannestad K
    Immunology; 2000 Aug; 100(4):455-61. PubMed ID: 10929072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engagement of the B lymphocyte antigen receptor induces presentation of intrinsic immunoglobulin peptides on major histocompatibility complex class II molecules.
    Bartnes K; Hannestad K
    Eur J Immunol; 1997 May; 27(5):1124-30. PubMed ID: 9174601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive presentation of dominant epitopes from endogenous naturally processed self-beta 2-microglobulin to class II-restricted T cells leads to self-tolerance.
    Guéry JC; Sette A; Appella E; Adorini L
    J Immunol; 1995 Jan; 154(2):545-54. PubMed ID: 7814867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell recognition of endogenous IgG2a expressed in B lymphoma cells.
    Bikoff EK; Yu H; Eckhardt LA
    Eur J Immunol; 1988 Mar; 18(3):341-8. PubMed ID: 3258563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of mouse T lymphocyte-induced suppression of the IgG2ab allotype and T lymphocyte tolerance to IgG2ab.
    Majlessi L; Bordenave G
    Arch Immunol Ther Exp (Warsz); 2001; 49(6):407-15. PubMed ID: 11814234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo.
    de Jong JM; Schuurhuis DH; Ioan-Facsinay A; Welling MM; Camps MG; van der Voort EI; Huizinga TW; Ossendorp F; Verbeek JS; Toes RE
    Immunology; 2006 Dec; 119(4):499-506. PubMed ID: 16995881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self gamma2a(b) protein is presented in vivo by gamma2a(b) B cells but not by dendritic cells.
    Granucci F; Foti M; Cossarizza A; Ricciardi-Castagnoli P
    J Immunol; 1997 Aug; 159(4):1794-9. PubMed ID: 9257842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The P9 peptide sidechain specificity of I-Ad.
    Bartnes K; Li X; Briand JP; Travers PJ; Hannestad K
    Immunol Lett; 1999 Dec; 70(3):199-202. PubMed ID: 10656674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.
    Bartnes K; Leon F; Briand JP; Travers PJ; Hannestad K
    Eur J Immunol; 1999 Jan; 29(1):189-95. PubMed ID: 9933100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
    Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
    J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mAb against hen egg-white lysozyme regulate its presentation to CD4(+) T cells.
    Guermonprez P; Lo-Man R; Sedlik C; Rojas MJ; Poljak RJ; Leclerc C
    Int Immunol; 1999 Nov; 11(11):1863-72. PubMed ID: 10545490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune responses to self peptides naturally presented by murine class II major histocompatibility complex molecules.
    Rider BJ; Fraga E; Yu Q; Singh B
    Mol Immunol; 1996; 33(7-8):625-33. PubMed ID: 8760274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of overlapping class I and class II H-2d-restricted T cell determinants of influenza virus N1 neuraminidase that require infectious virus for presentation.
    Wysocka M; Eisenlohr LC; Otvos L; Horowitz D; Yewdell JW; Bennink JR; Hackett CJ
    Virology; 1994 May; 201(1):86-94. PubMed ID: 7513927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presentation of IgG2a antigens to class II-restricted T cells by stably transfected B lymphoma cells.
    Bikoff EK; Eckhardt LA
    Eur J Immunol; 1989 Oct; 19(10):1903-9. PubMed ID: 2479567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed isotype class II antigen expression. A novel class II molecule is expressed on a murine B cell lymphoma.
    Spencer JS; Kubo RT
    J Exp Med; 1989 Mar; 169(3):625-40. PubMed ID: 2647893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.